1. Home
  2. PCH vs AMRX Comparison

PCH vs AMRX Comparison

Compare PCH & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCH
  • AMRX
  • Stock Information
  • Founded
  • PCH 1903
  • AMRX 2002
  • Country
  • PCH United States
  • AMRX United States
  • Employees
  • PCH N/A
  • AMRX N/A
  • Industry
  • PCH Real Estate Investment Trusts
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCH Real Estate
  • AMRX Health Care
  • Exchange
  • PCH Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • PCH 3.3B
  • AMRX 2.7B
  • IPO Year
  • PCH N/A
  • AMRX N/A
  • Fundamental
  • Price
  • PCH $41.77
  • AMRX $8.47
  • Analyst Decision
  • PCH Buy
  • AMRX Strong Buy
  • Analyst Count
  • PCH 5
  • AMRX 5
  • Target Price
  • PCH $48.50
  • AMRX $10.00
  • AVG Volume (30 Days)
  • PCH 420.1K
  • AMRX 1.1M
  • Earning Date
  • PCH 10-28-2024
  • AMRX 11-08-2024
  • Dividend Yield
  • PCH 4.31%
  • AMRX N/A
  • EPS Growth
  • PCH N/A
  • AMRX N/A
  • EPS
  • PCH 0.20
  • AMRX N/A
  • Revenue
  • PCH $1,058,432,000.00
  • AMRX $2,680,420,000.00
  • Revenue This Year
  • PCH N/A
  • AMRX $17.56
  • Revenue Next Year
  • PCH $1.14
  • AMRX $3.23
  • P/E Ratio
  • PCH $210.26
  • AMRX N/A
  • Revenue Growth
  • PCH 3.49
  • AMRX 12.32
  • 52 Week Low
  • PCH $37.06
  • AMRX $4.16
  • 52 Week High
  • PCH $50.04
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • PCH 44.65
  • AMRX 45.78
  • Support Level
  • PCH $41.00
  • AMRX $7.52
  • Resistance Level
  • PCH $42.78
  • AMRX $9.48
  • Average True Range (ATR)
  • PCH 1.12
  • AMRX 0.35
  • MACD
  • PCH 0.02
  • AMRX 0.02
  • Stochastic Oscillator
  • PCH 52.84
  • AMRX 48.59

About PCH PotlatchDeltic Corporation

PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: